First-in-man clinical trial for INmune Bio’s novel therapy to prime the patient’s natural killer cells to attack their cancer.
For over 16 years, PHARMExcel and Moorfields Eye Hospital have collaborated to push the boundaries of ophthalmology clinical research. Discover how this visionary alliance is accelerating quality clinical trial outcomes.
Learn how a CRO’s relationship with its Clinical Research Facility can make a difference to trial outcomes.
Working in partnership with the Experimental Cancer Medicine Centre (ECMC) Network, PHARMExcel lead the phase I clinical trial TRALA.
The process of taking a pharmaceutical drug through its drug discovery pathway can be challenging, time consuming, and expensive. It’s why more and more leading biotech and pharma companies choose to outsource clinical research work to contract research organisations (CROs) instead.
Following its reputation of excellence in delivering investigator-led studies, PHARMExcel was selected to manage the Covid-19 vaccine booster study.
BACKGROUND PHARMExcel was selected to manage a UK, Phase II, combined Investigational Medicinal Product (IMP)/Medical Device study for COVID-19 patients hospitalised in ICU. We were asked to provide Project Management (PM), Monitoring and Safety oversight for the study, from protocol development to close-out. The study involved two sites and numerous teams responsible for key elements…
